Sentences with phrase «used by cancer patients»

For years it has been used by cancer patients undergoing chemotherapy to battle the often debilitating effects of nausea.

Not exact matches

Shkreli originally became infamous for his other former company Turing Pharma's 5,000 % price hike for a drug used by cancer and AIDS patients.

Martin Shkreli, unaffectionately known as the «pharma bro» — and infamous for his decision to hike the list price of Daraprim, a drug used by HIV / AIDS and cancer patients to combat infections, by more than 5,000 % in 2015 under his former company Turing Pharmaceuticals — was convicted on three criminal securities fraud and conspiracy charges by a Brooklyn jury on Friday.

Printed materials can be used to replace bones: A woman in the Netherlands had much of her skull replaced by a printed plastic one, and a cancer patient in Spain received a printed titanium rib cage.

Using an app created by a company called Medical Realities, viewers from around the globe, each presumably with an iron constitution, witnessed a surgeon at the Royal London NHS Hospital delve into the bowels of a 70 - year - old cancer patient.

This drug is used by some AIDS and cancer patients and treats the parasitic infection toxoplasmosis.

The use of imaging by cancer patients, as pioneered by the Simontons (see chapter 8), is one productive application.

Mr. Cuomo said he will use an executive order to revive the Antonio G. Olivieri controlled substances therapeutic research program, which was established by law in 1980 and discontinued soon after, and allow up to 20 hospitals to dispense marijuana to approved patients suffering from cancer and other serious illnesses.

Using the electronic health records of patients from the Veterans Health Administration between 1998 and 2007, researchers were able to determine the likelihood that a diagnosis of pancreatic cancer follows a diagnosis of acute pancreatitis, how often pancreatic cancer is preceded by acute pancreatitis, and the time between an initial episode of acute pancreatitis and diagnosis of pancreatic cancer.

A new study led by UNC Lineberger Comprehensive Cancer Center researchers identifies distinct patterns of side effects that patients could use to guide their choices.

«If you give patients immune cells to eradicate any remaining cancer cells that might be present,» he says, «those immune cells would not be prevented from doing their job by ongoing immune suppression drugs that are being used in patients treated with conventional transplant approaches.»

A fundamental error, according to several epidemiologists, is that Tsuda compared the results of the Fukushima survey, which used advanced ultrasound devices that detect otherwise unnoticeable growths, with the roughly three cases of thyroid cancer per million found by traditional clinical examinations of patients who have lumps or symptoms.

The study, «AKR1B1 promotes basal - like breast cancer progression by a positive feedback loop that activates the EMT program,» which has been published in The Journal of Experimental Medicine, suggests that an inhibitor of this enzyme currently used to treat diabetes patients could be an effective therapy for this frequently deadly form of cancer.

A large Australian trial showing that daily use of nicotinamide, a form of vitamin B3, for 12 months reduced the incidence of new non-melanoma skin cancers by 23 % in patients at high risk for skin cancer

Autophagy has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation; however, autophagy as a potential druggable mechanism in patients who become resistant to BRAF inhibitors has not been investigated.

«The phi test helps physicians distinguish prostate cancer from benign conditions by utilizing three different PSA markers (PSA, freePSA and p2PSA) as part of a sophisticated algorithm to more reliably determine the probability of cancer in patients with elevated PSA levels,» said Kevin Slawin, MD, director, Vanguard Urologic Institute at Memorial Hermann Medical Group, clinical professor of Urology at Baylor College of Medicine and director of Urology, Memorial Hermann Hospital ‐ Texas Medical Center, who performed some of the key research that led to the development of the phi test and who also began using the test in February.

Saatchi, which is owned by France's Publicis Groupe, SA, chose LifeStraw over a field of competitors that included a reusable controller to improve the distribution of IV fluids, a collapsible wheel that can be folded down for easier storage when not in use on bicycles or wheelchairs, an energy - efficient laptop designed for children in developing countries, a 3 - D display that uses special optics and software to project a hologramlike image of patient anatomy for cancer treatment, an inkjet printing system for fabricating tissue scaffolds on which cells can be grown, a visual prosthesis for bypassing a diseased or damaged eye and sending signals directly to the brain, books with embedded sound tracks to help educate illiterate adults on health issues, a phone that provides telecommunications coverage to poor rural populations in developing countries, and a brain - computer interface designed to help paralyzed people communicate via neural signals.

Using data from a previously published, multi-center study funded by the National Cancer Institute, researchers aimed to identify the possible benefits of assigning patient navigators to women recently diagnosed with breast cCancer Institute, researchers aimed to identify the possible benefits of assigning patient navigators to women recently diagnosed with breast cancercancer.

Here's one example of how this information might be useful for doctors and patients: Irinotecan is a drug only indicated by the FDA for use in colon cancer.

Researchers think just a fraction of the dose of GM - CSF usually used in cancer patients may also help reset an immune system disrupted by extreme trauma.

After excluding patients with liver cancer before the follow ‐ up index dates, 1,553 patients who had continuously received daily aspirin for at least 90 days were randomly matched 1:4 with 6,212 patients who had never received anti platelet therapy by means of propensity scores consisting of baseline characteristics, the index date and nucleos (t) ide analogue (NA) use during follow ‐ up.

«The microbiome appears to shape a patient's response to cancer immunotherapy, which opens potential pathways to use it to assess a patient's fitness for immunotherapy and to manipulate it to improve treatment,» said Wargo, who is also co-leader of the Melanoma Moon Shot ™, part of MD Anderson's Moon Shots Program ™ to reduce cancer deaths by accelerating development of therapies from scientific discoveries.

The Decision Counseling Program © developed by Dr. Myers and colleagues differs from previous decision aids in that a nurse educator uses the program not only to provide information about options, but also to identify and weigh the importance of things that matter to the patient (e.g., worry about treatment side effects, concern about developing aggressive cancer).

By using a small molecule called 2 - bromo - palmitate (2BP) that inhibits these palmitate - adding enzymes, the researchers surmise that cancer patients might be able to one day make their cells more sensitive to cancer - fighting EGFR inhibitors.

Their findings could help to improve breast cancer prevention by targeting these specific biological mechanisms with cancer therapies in at risk patients and potentially lead the way for a new strategy for the use of preventative treatments.

Buoyed by these results, Dana - Farber researchers are working to create a derivative of dBET1 that can be used as a drug in human patients — and to extend the conjugate strategy for the treatment of other cancers and other genetically - caused diseases.

«By conducting such a screen, we found one specific combination of agents that are already being used clinically that potentially could be used for a specific group of patients — those with BRAF - mutant cancers.»

«By using an animal model to expand tumor cells recently removed from patients, we hoped to re-create more closely what actually happens in patients with pancreatic cancer rather than by using existing artificial cell lines,» said Wei Zhang, Ph.D., an endowed Hanes and Willis Family Professor in cancer at Wake Forest School of Medicine, a part of Wake Forest Baptist, and principal investigator of the studBy using an animal model to expand tumor cells recently removed from patients, we hoped to re-create more closely what actually happens in patients with pancreatic cancer rather than by using existing artificial cell lines,» said Wei Zhang, Ph.D., an endowed Hanes and Willis Family Professor in cancer at Wake Forest School of Medicine, a part of Wake Forest Baptist, and principal investigator of the studby using existing artificial cell lines,» said Wei Zhang, Ph.D., an endowed Hanes and Willis Family Professor in cancer at Wake Forest School of Medicine, a part of Wake Forest Baptist, and principal investigator of the study.

A team of scientists at the Children's Research Institute at UT Southwestern (CRI) has made a discovery that suggests cancer cells benefit more from antioxidants than normal cells, raising concerns about the use of dietary antioxidants by patients with cancer.

By contrast, the neoantigen vaccine is custom - made for each patient using antigens produced by mutations unique to the patient's cancer and only present on cancer cells, thus bypassing the nature immune tolerance procesBy contrast, the neoantigen vaccine is custom - made for each patient using antigens produced by mutations unique to the patient's cancer and only present on cancer cells, thus bypassing the nature immune tolerance procesby mutations unique to the patient's cancer and only present on cancer cells, thus bypassing the nature immune tolerance process.

A research team, led by Chao Cheng, Ph.D., Assistant Professor in the Department of Genetics at The Geisel School of Medicine at Dartmouth, used gene expression data from breast cancer patients to computationally infer the presence of different types of immune cells.

See full infographic: JPGINFOGRAPHIC BY JUDE BUFFUMFueled in part by interest generated by Champions, more and more scientists now use PDX mice to study the potential cancer drug responses of individual patientBY JUDE BUFFUMFueled in part by interest generated by Champions, more and more scientists now use PDX mice to study the potential cancer drug responses of individual patientby interest generated by Champions, more and more scientists now use PDX mice to study the potential cancer drug responses of individual patientby Champions, more and more scientists now use PDX mice to study the potential cancer drug responses of individual patients.

Assessment of Distress, Unmet Needs, and Receipt of Care Plans Among Cancer Survivors in Georgia: A Needs Assessment Cancer Survivorship in Georgia Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer Georgia's Cancer Survivorship Needs Survey Life After Cancer: Survivorship by the Numbers Resources for Health Care Professionals Survivorship Resources and Services

«Right now, if a doctor wants to use multiple drugs to treat a cancer, they often can't do it because the cumulative toxic effects of the drugs would not be tolerated by the patient,» Davis says.

$ 1.8 M Supports Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development of Ovarian Cancer GMNews.com - March 2, 2016 Differences in Type of Small Protein may further Elucidate Lung Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the Lung Cancer Ribbon?

We seek to «Track and Treat» the cancer cells present in patients» tissues by using lineage tracing, as well as sequencing technologies, to determine the molecular mechanisms responsible for the dissemination of cancer cells to various organs, and resistance to current therapies.

«The primary goal of GEP testing is to identify patients at high recurrence risk who will benefit from chemotherapy, while allowing patients with a low recurrence risk to forego chemotherapy, potentially offsetting the test costs with savings from reductions in chemotherapy use,» wrote authors led by Young Chandler, PhD, of the Georgetown Lombardi Comprehensive Cancer Center in Washington, DC.

Our goal is to reach out to patients with metastatic breast cancer throughout the USA and Canada in order to study their cancer using cutting - edge genomic and molecular research studies performed at the Broad Institute by allowing patients to participate in these studies regardless of where they live.

Through this development, the Cancer Center can offer potentially curative bone marrow transplants to an increasing number of patients by using alternative bone marrow donors.

Filgrastim is approved by the U.S. Food and Drug Administration (FDA) for use in cancer patients who are at risk of developing infection due to cancer treatment.

Presentations included: Genetics Primer & Clinical Updates by Linford Williams, MS, LGC; Genetics and Women's Health: Seeing and Foreseeing the Ethical Challenges Ahead by Ruth Farrell, MD, MA; Preimplantation Genetic Screening and Diagnosis: What You Need to Know by Marissa Coleridge, MS, LGC; Evolution of Prenatal Genetic Screening and Testing: NIPT and Beyond by Jeff Chapa, MD, MBA; Promises and Pitfalls of Prenatal Whole Exome Sequencing by Amanda Kalan, MD; Fertility Preservation and Cancer: Survivors, Previvors, and the Newly Diagnosed by Rebecca Flyckt, MD; Improving Access to Cancer Genetics via Telegenetics by Ryan Noss, MS, LGC; Breast Cancer: Management of Moderate Penetrance Predisposition Genes by Holly Pederson, MD; Use of Hormonal and Non-hormonal Therapies in Breast Cancer Survivors and Women at High Risk for Breast / Gyn Cancers by Holly Thacker, MD; Addressing Commonly Asked Patient Questions about Genetics by Rebekah Moore, MS, LGC, Christina Rigelsky, MS, LGC and Allison Schreiber, MS, LGC; and a panel discussion on Genetic Testing Reimbursement featuring Bruce Rogen, MD, MPH and John Yao, MD, MBA, MPH, which was moderated by Daniel Sullivan, MD..

«A number of these assays and associated bioinformatics software have been validated for use in Invivoscribe's own «LabPMM» clinical laboratories, and they are currently being used by leading cancer treatment centers and pharmaceutical partners, both to optimize treatments for patients, and to stratify, enroll, and track residual disease in patients in international phase II and phase III clinical studies.

These reagents included goat polyclonal antisera to MuLV (whole virus and gp69 / 71Env, respectively) available at ATCC (VR - 1537 and VR - 1521, respectively), and a rabbit anti-XMRV polyclonal antiserum (kindly provided by Ila Singh) and a rat anti-SFFV (7C10) monoclonal antibody (kindly provided by Sandra Ruscetti) used previously to detect XMRV protein expression and antibodies in prostate cancer and CFS patients, respectively [11, 13, 21].

This is the same nested PCR test used by Urisman et al. and Lombardi et al. to detect 413 - bp XMRV gag sequences in prostate cancer and CFS patients, respectively [11, 12].

An aliquot of coded plasma from the CFS and healthy controls was tested at RKI by an ELISA using recombinant Gag and Env proteins used recently to investigate XMRV infection in German prostate cancer patients [14].

In addition, testing at CDC utilized the nested XMRV gag PCR assay used by Lombardi et al. and Urisman et al. to identify XMRV infection in CFS and prostate cancer patients, respectively [11, 12].

SEngine Precision Medicine, instead, is pursuing an innovative approach for the development of novel targets and drugs for cancer therapy by using primary patient organoids initially derived for our diagnostic assay.

«A number of our assays and associated bioinformatics software are currently being used by leading cancer centers and pharmaceutical partners in support of optimizing treatments for patients, and to stratify, enroll, and track MRD in patients in international phase II and phase III clinical studies.

In a clinical trial, lung cancer patients who used an app developed by an Israel - based company lived seven months longer than patients who only received standard care.

We help patients understand their cancer risk and work to prevent cancer - causing behaviors, such as tobacco use by children.